Phase II/III results of a trial of antitumor necrosis factor multivalent NANOBODY compound ozoralizumab in patients with rheumatoid arthritis
Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults
The FDA has issued communications addressing risks associated with some compounded GLP-1 products, and the regulatory landscape for compounded medications continues to evolve
When your cells can't produce energy efficiently, rest doesn't restore you
The 2022 ASMBS/IFSO guidelines state that metabolic and bariatric surgery has extensive evidence for safety, efficacy, and durability, with overall long-term outcomes often exceeding 60% excess weight loss
That equates to tens of millions of consumers who have already cycled through appetite suppression